| Ms Rosa Nilo Dastrange, OD | |
|
9850 Key West Ave, Rockville, MD 20850-3960 | |
| (240) 314-0160 | |
| Not Available |
| Full Name | Ms Rosa Nilo Dastrange |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 15 Years |
| Location | 9850 Key West Ave, Rockville, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083925457 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | TA2186 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kaiser Foundation Health Plan Of The Mid-atlantic States,inc | 3779495858 | 1673 |
News Archive
Logical Therapeutics, Inc., a Waltham, MA-based biopharmaceutical company announced today the positive results of a Phase I/II clinical trial evaluating the gastrointestinal (GI) safety of its investigational drug LT-NS001, the first of a new class of bio-activated prodrugs being developed for the chronic treatment of arthritic conditions.
The condition of mice with a genetic blood disease called beta-thalassemia improved significantly following treatment of their blood forming cells with a gene that enabled them to produce the type of hemoglobin normally found only in the fetus.
The University of Sydney, in partnership with BreastScreen NSW and Ziltron, has developed a pioneering web-based programme to monitor the performance of radiologists in detecting and diagnosing abnormalities in breast x-rays. Currently commencing its nationwide rollout, the BREAST Project has the potential to improve the early detection of breast cancer through screening and in turn reduce breast cancer mortality and morbidity.
Professor Mike Stratton, Director of the Wellcome Trust Sanger Institute, will speak about 'the evolution of the cancer genome' at the prestigious 2012 American Association for the Advancement of Science annual meeting. The AAAS annual meeting is one of the world's most widely recognized science events.
Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced the publication of a preclinical study demonstrating highly specific, functional correction of the alpha 1-antitrypsin (A1AT) gene defect in patient-derived induced pluripotent stem cells (iPSCs) using zinc finger nucleases.
› Verified 2 days ago
| Provider Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1952461816 PECOS PAC ID: 3779495858 Enrollment ID: O20040105000308 |
News Archive
Logical Therapeutics, Inc., a Waltham, MA-based biopharmaceutical company announced today the positive results of a Phase I/II clinical trial evaluating the gastrointestinal (GI) safety of its investigational drug LT-NS001, the first of a new class of bio-activated prodrugs being developed for the chronic treatment of arthritic conditions.
The condition of mice with a genetic blood disease called beta-thalassemia improved significantly following treatment of their blood forming cells with a gene that enabled them to produce the type of hemoglobin normally found only in the fetus.
The University of Sydney, in partnership with BreastScreen NSW and Ziltron, has developed a pioneering web-based programme to monitor the performance of radiologists in detecting and diagnosing abnormalities in breast x-rays. Currently commencing its nationwide rollout, the BREAST Project has the potential to improve the early detection of breast cancer through screening and in turn reduce breast cancer mortality and morbidity.
Professor Mike Stratton, Director of the Wellcome Trust Sanger Institute, will speak about 'the evolution of the cancer genome' at the prestigious 2012 American Association for the Advancement of Science annual meeting. The AAAS annual meeting is one of the world's most widely recognized science events.
Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced the publication of a preclinical study demonstrating highly specific, functional correction of the alpha 1-antitrypsin (A1AT) gene defect in patient-derived induced pluripotent stem cells (iPSCs) using zinc finger nucleases.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Rosa Nilo Dastrange, OD 9850 Key West Ave, Rockville, MD 20850-3960 Ph: (240) 314-0160 | Ms Rosa Nilo Dastrange, OD 9850 Key West Ave, Rockville, MD 20850-3960 Ph: (240) 314-0160 |
News Archive
Logical Therapeutics, Inc., a Waltham, MA-based biopharmaceutical company announced today the positive results of a Phase I/II clinical trial evaluating the gastrointestinal (GI) safety of its investigational drug LT-NS001, the first of a new class of bio-activated prodrugs being developed for the chronic treatment of arthritic conditions.
The condition of mice with a genetic blood disease called beta-thalassemia improved significantly following treatment of their blood forming cells with a gene that enabled them to produce the type of hemoglobin normally found only in the fetus.
The University of Sydney, in partnership with BreastScreen NSW and Ziltron, has developed a pioneering web-based programme to monitor the performance of radiologists in detecting and diagnosing abnormalities in breast x-rays. Currently commencing its nationwide rollout, the BREAST Project has the potential to improve the early detection of breast cancer through screening and in turn reduce breast cancer mortality and morbidity.
Professor Mike Stratton, Director of the Wellcome Trust Sanger Institute, will speak about 'the evolution of the cancer genome' at the prestigious 2012 American Association for the Advancement of Science annual meeting. The AAAS annual meeting is one of the world's most widely recognized science events.
Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced the publication of a preclinical study demonstrating highly specific, functional correction of the alpha 1-antitrypsin (A1AT) gene defect in patient-derived induced pluripotent stem cells (iPSCs) using zinc finger nucleases.
› Verified 2 days ago
Alice P Laflamme, OD Optometrist Medicare: Medicare Enrolled Practice Location: 3204 Tower Oaks Blvd Ste 300, Rockville, MD 20852 Phone: 301-231-5088 | |
Shady Grove Eye & Vision Care, Llc Optometrist Medicare: Medicare Enrolled Practice Location: 15200 Shady Grove Rd, Suite 100, Rockville, MD 20850 Phone: 301-670-1212 Fax: 301-216-9692 | |
Pioneer Optical Company Optometrist Medicare: Not Enrolled in Medicare Practice Location: 50 W Edmonston Dr Ste 103, Rockville, MD 20852 Phone: 301-251-6735 | |
Howard Budner & Associates O.d. P.a Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4110 Aspen Hill Rd, 300, Rockville, MD 20853 Phone: 301-871-0180 Fax: 301-871-0179 | |
Sheila Wood, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 11802 Rockville Pike Ste B, Rockville, MD 20852 Phone: 301-770-7780 Fax: 301-770-1433 | |
Chun H Auyeung, O.D Optometrist Medicare: Accepting Medicare Assignments Practice Location: 5576 Norbeck Rd Unit B, Rockville, MD 20853 Phone: 301-238-7199 Fax: 301-977-4664 |